In the first study aiming to provide a comprehensive analysis of the clinical significance of SLFN11 as a predictive biomarker to DDA on a wide range of cancer models, including ovarian cancer, the cutoff of 31 H-score showed a good predictive power [46]. This evidence concerns the gene SLFN11 and ovarian carcinoma.